Skip to main content
Signal8

Deming David H

SEC insider (Form 3/4/5 filer). CIK 0001641063. Director at Phio Pharmaceuticals Corp. (PHIO). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 5, 2026. Located in KING OF PRUSSIA, PA.

Companies Deming David H has filed insider reports for

  • Phio Pharmaceuticals Corp. (PHIO): Director
Deming David H profile photo

Deming David H

CIK: 0001641063

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Phio Pharmaceuticals Corp. logo
PHIO

Phio Pharmaceuticals Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Phio Pharmaceuticals Corp. logo
    PHIO

    Phio Pharmaceuticals Corp.

    Feb 5, 2026
    Award
    Direct
    23.8K shares-
  • Phio Pharmaceuticals Corp. logo
    PHIO

    Phio Pharmaceuticals Corp.

    Sep 11, 2025
    Award
    Direct
    14K shares-

1-2 of 2